Ethnopharmacological relevance: Pistacia lentiscus L. (PLL) is traditionally used in Sardinian folk medicine for osteoarthritis (OA) and represents a source of polyphenols with potential antioxidant and anti-inflammatory activity. Aim of the study: To investigate the phenolic profile, the antioxidant potency, the total phenolic content, cytotoxicity, and anti-inflammatory properties of an aqueous leaf extract of PLL to explore its possible relevance in OA. Materials and methods: Total phenolic content was assessed by the Folin–Ciocalteu spectrophotometric method. The polyphenols were also characterized by a High-Performance Liquid Chromatography (HPLC). The antioxidant ability was assessed by the 2,2-diphenyl-1-picrylhydrazyl (DPPH). The anti-inflammatory activity was examined through COX-1 and COX-2 inhibition while, the cytotoxicity was evaluated in dysplastic oral keratinocytes (DOK), human gingival fibroblasts (HGnF), and human periodontal ligament fibroblasts (HPLF) by using the WST-1 and the xCELLigence assays. Results: The total phenolic content was 249.78 ± 37.10 mg GAE/g DW, where myricetin glycoside and catechin were the most abundant compounds. The DPPH scavenging capacity showed an IC50 value 32.22 ± 6.43 μg/mL indicating considerable antioxidant potential of the extract. At 10 μg/mL the extract inhibited COX-1 and COX-2 by 92.07% and 71.04%, respectively, with IC50 values of 5.14 μg/mL and 13.87 μg/mL. No relevant cytotoxicity was observed at lower concentrations in the tested cell lines. Conclusion: PLL extract shows high total phenolic content, which together with the DPPH document strong antioxidant potency of the compound. This data together with the marked anti-inflammatory activity, and the limited cytotoxicity, support the potential interest of PLL extract as a natural candidate to counteract OA manifestations.

Exploring the pharmaceutical potential of Pistacia lentiscus L. acqueus extracts as a therapeutic agent against osteoarthritis manifestations: an in vitro study / Mastandrea, G., Sardellitti, L., Szotakova, B., Langhansova, L., Bullitta, S., Serralutzu, F., Dore, A., Doria, C., Caggiari, G., Milia, E.P.. - In: JOURNAL OF ETHNOPHARMACOLOGY. - ISSN 0378-8741. - 370:(2026). [10.1016/j.jep.2026.122071]

Exploring the pharmaceutical potential of Pistacia lentiscus L. acqueus extracts as a therapeutic agent against osteoarthritis manifestations: an in vitro study

Mastandrea G.;Sardellitti L.;Doria C.;Caggiari G.;Milia E. P.
2026-01-01

Abstract

Ethnopharmacological relevance: Pistacia lentiscus L. (PLL) is traditionally used in Sardinian folk medicine for osteoarthritis (OA) and represents a source of polyphenols with potential antioxidant and anti-inflammatory activity. Aim of the study: To investigate the phenolic profile, the antioxidant potency, the total phenolic content, cytotoxicity, and anti-inflammatory properties of an aqueous leaf extract of PLL to explore its possible relevance in OA. Materials and methods: Total phenolic content was assessed by the Folin–Ciocalteu spectrophotometric method. The polyphenols were also characterized by a High-Performance Liquid Chromatography (HPLC). The antioxidant ability was assessed by the 2,2-diphenyl-1-picrylhydrazyl (DPPH). The anti-inflammatory activity was examined through COX-1 and COX-2 inhibition while, the cytotoxicity was evaluated in dysplastic oral keratinocytes (DOK), human gingival fibroblasts (HGnF), and human periodontal ligament fibroblasts (HPLF) by using the WST-1 and the xCELLigence assays. Results: The total phenolic content was 249.78 ± 37.10 mg GAE/g DW, where myricetin glycoside and catechin were the most abundant compounds. The DPPH scavenging capacity showed an IC50 value 32.22 ± 6.43 μg/mL indicating considerable antioxidant potential of the extract. At 10 μg/mL the extract inhibited COX-1 and COX-2 by 92.07% and 71.04%, respectively, with IC50 values of 5.14 μg/mL and 13.87 μg/mL. No relevant cytotoxicity was observed at lower concentrations in the tested cell lines. Conclusion: PLL extract shows high total phenolic content, which together with the DPPH document strong antioxidant potency of the compound. This data together with the marked anti-inflammatory activity, and the limited cytotoxicity, support the potential interest of PLL extract as a natural candidate to counteract OA manifestations.
2026
Exploring the pharmaceutical potential of Pistacia lentiscus L. acqueus extracts as a therapeutic agent against osteoarthritis manifestations: an in vitro study / Mastandrea, G., Sardellitti, L., Szotakova, B., Langhansova, L., Bullitta, S., Serralutzu, F., Dore, A., Doria, C., Caggiari, G., Milia, E.P.. - In: JOURNAL OF ETHNOPHARMACOLOGY. - ISSN 0378-8741. - 370:(2026). [10.1016/j.jep.2026.122071]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/394433
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact